Oral Health in Adults: Social Gradients and Correlation With Cardiovascular Health
HUSK
Oral Health in Adults: Predictors, Social Gradients and Correlation With Cardiovascular Health in Women and Men
1 other identifier
observational
1,200
1 country
1
Brief Summary
Non-communicable diseases (NCDs) are rising in prevalence because of aging, unhealthy diet and sedentary lifestyle, and common NCDs are caries and periodontitis (here oral diseases) and cardiovascular disease (CVD). Association between oral diseases and CVD has been observed in epidemiological studies, and suggested mechanisms include transfer of oral pathogen bacteria and pro-inflammatory mediators to other organs triggering immune response and systemic inflammation. Circulating mediators may initiate a response in the liver with production of C-reactive protein, serum amyloid A and increased tryptophan degradation, that contribute to CV inflammation and atherosclerosis. We have demonstrated that higher serum levels of these markers are associated with presence of hypertension and obesity and with higher risk of CVD. However, CVD and oral diseases also share many of the same risk factors, including hypertension, obesity, diabetes and smoking. Since the association of oral disease with CV risk factors mostly has been demonstrated in cross-sectional studies, the direction has not been ascertained. These CVD risk factors lead to changes in the heart and arteries (preclinical CVD); more harmful in women than men. If these conditions can impact development of oral diseases is not been investigated in large studies. Socio-economic inequalities have been reported for oral diseases and are linked to low socio-economic status (SES). It is unknown whether CV health and SES in midlife may impact prevalence of oral diseases later in life. It is also unknown if the oral microbiome differ by periodontitis severity and can be associated with inflammatory biomarkers, CV risk factors and preclinical CVD. The project will be performed in adults approaching the retirement age in Vestland county. We will combine their data from the ongoing Hordaland Oral Health Survey with their data from three surveys in the longitudinal Hordaland Health Study performed in the period 1992-2020.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2019
CompletedFirst Submitted
Initial submission to the registry
April 4, 2022
CompletedFirst Posted
Study publicly available on registry
March 7, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMarch 18, 2025
March 1, 2025
6.5 years
April 4, 2022
March 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (13)
Describe Oral health status
describe the participants periodontal status, caries experience (DMFT given as a number) and number of missed teeth and their self-reported oral health based on a questionaire. The periodontal disease will be divided in mild, moderate and severe.Oral health will be described as the outcome measures: caries, periodontal health and tooth loss. Caries will be measured as number of teeth or surfaces with caries. We will also use DMFT measure defined as the sum of decayed, missed, filled teeth for each participant. The number of participants is 1325. Case definition of periodontal health in an intact periodontium PD ≤ 3 mm No interdental REC ≥1 mm BoP \< 10% (mean at patient level) Mild periodontitis * 2 interdental sites with CAL ≥ 3 mm and ≥ 2 interdental sites with PD ≥ 4 mm (not on the same tooth) or * 1 interdental site with PD ≥ 5 mm Moderate periodontitis * 2 interdental sites with CAL ≥4 mm (not on the same tooth) or * 2 interdental sites with PD ≥5 mm (not on
3 years
Prospective study associations of CV risk factors with oral diseases.
Hypertension is defined as SBP ≥140 mmHg and/or DBP ≥90 mmHg.
3 years
Prospective study associations of CV risk factors with oral diseases.
Diabetes is identified as HbA1c≥48mmol/mol or use of antidiabetic drug therapy.
3 years
Prospective study associations of CV risk factors with oral diseases.
The height will be measured in cm. .
3 years
Prospective study associations of CV risk factors with oral diseases.
weight will be measured in kilogram
3 years
Prospective study associations of CV risk factors with oral diseases.
BMI was calculated as weight (in kilograms) divided by height (in meters) squared
3 years
Prospective study associations of systemic risk factors with oral diseases.
Systemic inflammatory biomarkers While at the clinic, participants provided a non-fasting blood sample, kept on ice during transport, and then centrifuged and stored at -80 °C before analysis Neopterin, tryptophan, Kunurenine and kynurenine pathway metabolites (in nmol/L) were quantified by LC-tandem MS at Bevital, Bergen, Norway (www.bevital.no). Plasma hs-CRP (mg/L) was measured with an immuno-Matrix-Assisted Laser Desorption/Ionization-based assay.
3 years
SES indicators
Working arrangements will be measured as permanent , temporarly or non existing.
3 years
SES indicators
Social network will be evaluated : partner/married, living alone, live with other family-members
3 years
SES indicators
Education : measured as low, middle or high
3 years
SES indicators
Income measured in NOK and grouped in income ranges
3 years
Cardiovascular health and oral health
Arterial stiffness will be measured as carotid-femoral pulse wave velocity, and \>10 m/s will be set as arterial stiffness.
3 years
Cardiovascular health and oral health
Left ventricular hypertrophy is detected by echocardiography. Left ventricular mass \>47 g/height 2,7 for woman and \>50 g/height 2,7 for menn will be registrated aa left ventricular hypertrophy.
3 years
Eligibility Criteria
A cohort of community dwelling adults approaching the retirement age (born in 1950-1951), in Hordaland County (now Vestland).
You may qualify if:
- Participated in 3 Health surveys + one oral health survey
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oral Health Centre of Expertise in Western Norwaylead
- University of Bergencollaborator
- Norwegian Health Associationcollaborator
Study Sites (1)
Oral Health Centre of Expertice
Bergen, 5058, Norway
Biospecimen
Saliva and microbiological samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Research Department
Study Record Dates
First Submitted
April 4, 2022
First Posted
March 7, 2023
Study Start
July 1, 2019
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
March 18, 2025
Record last verified: 2025-03